Ulcerative colitis trials in Australia

In Australia 15 Also abroad 381

15 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Concord, South Brisbane
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 3Taking people
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Where
Nedlands, Parkville, South Brisbane
Age
2 years to 17 years
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07158242 · EU 2025-522518-22-01
No phaseTaking people
Specific and Novel Approaches to Care of Inflammatory Bowel Disease During Pregnancy: the PREGO Study
Where
Hobart, Melbourne, Sydney
Age
18 years and over
People
50
Run by
Austin Health
See details and how to joinNCT07916727
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Nedlands, South Brisbane, Westmead
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 3Taking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Adelaide, Camperdown, Clayton, Kurraba Point, Macquarie Island, Murdoch, New Lambton, South Brisbane, West Melbourne
Age
18 years and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
Phase 1/2Taking people
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
Adelaide, Brisbane, Joondalup, Macquarie Park, Melbourne, Nedlands, South Brisbane, Southport, Wollongong
Age
18 years to 75 years
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990
Phase 2Taking people
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
Camperdown, Murdoch, Parkville VIC, South Brisbane
Age
18 years and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Concord, Heidelberg, Liverpool, Melbourne, Murdoch, South Brisbane, Woolloongabba
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 2Taking people
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Where
Brisbane, Clayton, Perth, Westmead
Age
2 years to 11 years
People
24 worldwide
Run by
Pfizer
See details and how to joinNCT07470879 · EU 2025-523100-77-00
Phase 3Taking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Liverpool, Wollongong
Age
16 years to 80 years
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
Phase 2/3Taking people
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Where
Clayton, Murdoch, Nedlands, Westmead
Age
2 years to 17 years
People
120 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05076175
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
South Brisbane
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 1Taking people
A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis
Where
Perth
Age
18 years to 55 years
People
48
Run by
TrueLab Biopharmaceutical Co., Ltd
See details and how to joinNCT07526519
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Clayton, Parkville, South Brisbane, Westmead
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
Phase 2Taking people
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Birtinya, Box Hill, Maroochydore, Melbourne, Murdoch, Parkville
Age
18 years to 75 years
People
57 worldwide
Run by
Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727